Chengtan Liu

Title: Innovations by Chengtan Liu in Glaucoma Treatment

Introduction

Chengtan Liu is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. His innovative approach focuses on balancing the lamina cribrosa crossing pressure difference, which is crucial for improving the quality of life for glaucoma patients.

Latest Patents

Chengtan Liu holds a patent for a "Lamina cribrosa crossing pressure balance maintainer for constantly balancing lamina cribrosa crossing pressure difference, implantation device, and method for balancing lamina cribrosa crossing pressure difference." This implantable device is designed to maintain a constant balance of the lamina cribrosa crossing pressure difference. By doing so, it helps to recover or even reverse the deformation of the lamina cribrosa, thereby improving the tolerance of glaucoma patients to intraocular hypertension. This innovation aims to relieve nerve damage caused by pressure differences and addresses primary factors contributing to optic nerve damage in glaucoma patients.

Career Highlights

Chengtan Liu is affiliated with Wenzhou Medical University, where he continues to advance research in ophthalmology. His work has garnered attention for its potential to transform treatment methodologies for patients suffering from glaucoma, especially in middle and advanced stages.

Collaborations

Chengtan Liu collaborates with esteemed colleagues such as Yuanbo Liang and Shaodan Zhang. Their combined expertise enhances the research and development of innovative solutions in the medical field.

Conclusion

Chengtan Liu's contributions to glaucoma treatment through his patented innovations represent a significant advancement in ophthalmic care. His work not only addresses critical issues faced by patients but also paves the way for future research and development in this vital area of medicine.